<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Overview of the pathogenesis and causes of glomerulonephritis in children</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Overview of the pathogenesis and causes of glomerulonephritis in children</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Overview of the pathogenesis and causes of glomerulonephritis in children</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Patrick Niaudet, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">F Bruder Stapleton, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alison G Hoppin, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 17, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Glomerulonephritis (GN) generally presents as a constellation of findings that include hematuria, proteinuria, edema, and, often, hypertension [<a href="#rid1">1</a>]. GN is caused by a number of disorders that are all characterized by glomerular injury accompanied by inflammation. In some cases, GN may progress to kidney failure.</p><p>The pathogenesis and etiology of GN in children will be reviewed here. The approach to evaluating a child with GN is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6119.html" rel="external">"Glomerular disease: Evaluation in children"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Although the pathogenesis is not fully understood, available evidence suggests that most cases of GN are due to an autoimmune response, which is modified by genetic factors, to a variety of different etiologic agents including infectious agents [<a href="#rid2">2,3</a>]. The immunologic response, in turn, activates a number of biologic processes (eg, complement activation, leukocyte recruitment, and release of growth factors and cytokines) that result in glomerular inflammation and injury [<a href="#rid4">4,5</a>]. GN may be isolated to the kidney (primary GN) or be a component of a systemic disorder (secondary GN)  (<a class="graphic graphic_table graphicRef52094" href="/z/d/graphic/52094.html" rel="external">table 1</a>).</p><p>The immunologic mechanisms involved in the pathogenesis of GN are briefly reviewed here and are discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/3068.html" rel="external">"Mechanisms of immune injury of the glomerulus"</a>.)</p><p class="headingAnchor" id="H3"><span class="h2">Immunologic damage</span><span class="headingEndMark"> — </span>Humoral (also referred to T helper cell 2-regulated) immune response to a variety of inciting agents results in immunoglobulin (Ig) deposition and complement activation within the glomeruli  (<a class="graphic graphic_figure graphicRef52652" href="/z/d/graphic/52652.html" rel="external">figure 1</a>). In glomerular diseases that are primarily due to immunologic injury, immune complex deposition is an active process caused by in situ binding of antibodies to antigens localized within the glomeruli. The antigens may be structural glomeruli components, such as the Goodpasture antigen located in the glomerular basement membrane (GBM) in the non-collagenous domain of the alpha-3 chain of type IV collagen [<a href="#rid6">6</a>].</p><p>Alternatively, the antigens may be trapped or deposited within the glomerulus, including self-antigens such as chromatin components in lupus nephritis, neutrophil antigens in antineutrophil cytoplasmic autoantibody (ANCA) GN, IgA in IgA nephropathy, or exogenous antigens due to infectious agents such as bacteria (<em>Streptococcus</em>, <em>Staphylococcus</em>), viruses (hepatitis B), or tumor antigens [<a href="#rid7">7</a>]. These in situ-formed immune complexes may enlarge if there is further immune response consisting of polyclonal B-cell activation, which induces the formation of different antibodies. These include rheumatic factors IgM, anti-IgG, or anti-idiotypic antibodies that bind to these complexes. Autoantibodies to complement factors can induce C3 GN through complement activation.</p><p>Another possible mechanism for immune complex deposition is the passive process of trapping circulating immune complexes within the glomeruli. Although this process has been studied in animal models (serum sickness disease), it appears to be less commonly seen in human GN than in situ glomerular immune complex formation.</p><p>GN that is due to antibody formation requires the presence of T lymphocytes. CD4+T lymphocytes specific for nephritogenic autoantigens (proteinase-3, myeloperoxidase, Goodpasture antigen) are present in the circulation of patients with granulomatosis with polyangiitis or anti-GBM (Goodpasture) disease [<a href="#rid8">8,9</a>]. T lymphocytes may also cause GN in the absence of antibodies, as demonstrated in experimental animal models [<a href="#rid10">10,11</a>]. Although the mechanism for this cellular-mediated immunity is less well defined in humans, it appears to involve activation of both T cell lymphocytes and macrophages, particularly in rapidly progressive (crescentic) GN (RPGN). (See  <a class="medical medical_review" href="/z/d/html/3069.html" rel="external">"Mechanisms of glomerular crescent formation", section on 'Macrophages'</a> and  <a class="medical medical_review" href="/z/d/html/3069.html" rel="external">"Mechanisms of glomerular crescent formation", section on 'T cells'</a>.)</p><p class="headingAnchor" id="H4"><span class="h2">Secondary processes</span><span class="headingEndMark"> — </span>The primary immunologic pathologic process activates the following systems that contribute to the inflammatory response and glomerular damage  (<a class="graphic graphic_figure graphicRef52652" href="/z/d/graphic/52652.html" rel="external">figure 1</a>). (See  <a class="medical medical_review" href="/z/d/html/3068.html" rel="external">"Mechanisms of immune injury of the glomerulus", section on 'Inflammatory mechanisms of glomerular injury'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Complement system – The humoral immunologic response activates the classic complement pathway [<a href="#rid12">12</a>]. In some kidney disorders (eg, membranoproliferative type II and poststreptococcal GN), the alternative pathway is activated. Complement activation results in generation of chemotactic and chemokinetic peptides (C3a, C5a, and C3b) that attract white cells to the site of injury and formation of the membrane attack complex (C5b-C9), which may cause direct injury to glomerular cells [<a href="#rid13">13</a>] and results in the release of cytokines, reactive oxygen species (ROS), prostaglandins, and cell apoptosis [<a href="#rid14">14</a>]. (See  <a class="medical medical_review" href="/z/d/html/3920.html" rel="external">"Overview and clinical assessment of the complement system", section on 'Introduction'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Coagulation system – In patients with RPGN, direct injury to the endothelial cells activates the coagulation cascade. This results in thrombi formation and fibrin deposition that are important components in the formation of crescents. (See  <a class="medical medical_review" href="/z/d/html/3069.html" rel="external">"Mechanisms of glomerular crescent formation", section on 'Initiating events'</a> and  <a class="medical medical_review" href="/z/d/html/3069.html" rel="external">"Mechanisms of glomerular crescent formation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Leukocyte recruitment – A constant feature of GN is the glomerular infiltration of leukocytes (neutrophils, monocytes, and macrophages), which are sequentially recruited to the glomeruli by the coordinated release of chemoattractants (eg, C3a, C5a, and CXC chemokines). When activated, these cells generate ROS (such as hydrogen peroxide), lysosomal enzymes (which damage endothelial cells, the GBM, and the mesangium), and growth factors (which induce fibrin deposition, cell proliferation, and crescent formation). As in patients with granulomatosis with polyangiitis, who have kidney involvement, pathogenesis is due to adherence to renal endothelial cells and release proteases, ROS, and inflammatory cytokines, resulting in glomerular injury. (See  <a class="medical medical_review" href="/z/d/html/3980.html" rel="external">"The adaptive cellular immune response: T cells and cytokines", section on 'Cytokine profiles and functions of CD4+ T helper cell subsets'</a> and  <a class="medical medical_review" href="/z/d/html/3074.html" rel="external">"Pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis", section on 'Role of endothelial cells'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Glomerular cells – Injury to the glomerular endothelial and mesangial cells result in cell proliferation and adhesion molecule expression and the production and release of vasoactive molecules (endothelin and nitric oxide), cytokines, ROS, growth factors, and prostaglandins.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Growth factors and cytokines – Many growth factors and cytokines (eg, interleukins) are produced by glomerular cells and by inflammatory cells. These small peptides bind to specific cell surface receptors and may either promote or prevent kidney injury.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Growth factors such as platelet-derived growth factor, transforming growth factor-beta, and vascular endothelial growth factor have important roles in glomerular injury involving glomerular cell proliferation, extracellular matrix deposition, and sclerosis.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Interleukins (IL) are known to play an important role in the inflammatory response. IL-1, IL-8, and IL-18 have a proinflammatory action in GN [<a href="#rid15">15</a>]. IL-1 induces mesangial cell proliferation and promotes the synthesis of several substances. IL-8 is produced by mesangial cells and is a chemoattractant for granulocytes.</p><p></p><p class="headingAnchor" id="H5"><span class="h1">ETIOLOGIC CLASSIFICATION</span><span class="headingEndMark"> — </span>Because the differential diagnosis for GN is broad, using a classification schema is helpful to narrow the causes of childhood GN in a systematic manner. The etiology of GN can be classified by the following methods:</p><p class="bulletIndent1"><span class="glyph">●</span>Clinical presentation</p><p class="bulletIndent1"><span class="glyph">●</span>Histopathology</p><p></p><p>The preferred etiologic approach is to use the clinical presentation schema because the histopathologic method requires a biopsy sample.</p><p class="headingAnchor" id="H6"><span class="h2">Clinical presentation</span><span class="headingEndMark"> — </span>Children with GN can present in several scenarios, as discussed in the following sections. Each clinical presentation includes different kidney diseases. In addition, several glomerular disorders may be included in one or more clinical presentation (eg, IgA nephropathy). A presumptive clinical diagnosis is made based on the presentation, presence of extrarenal findings, family history, and laboratory testing including urinalysis. Histologic confirmation is made by kidney biopsy. (See  <a class="medical medical_review" href="/z/d/html/6119.html" rel="external">"Glomerular disease: Evaluation in children"</a>.)</p><p class="headingAnchor" id="H7"><span class="h3">Acute nephritic syndrome</span><span class="headingEndMark"> — </span>Acute nephritic syndrome typically presents as the sudden onset of hematuria (either gross or microscopic) with proteinuria, decreased glomerular filtration rate, and retention of sodium and water, which usually results in an elevated blood pressure and edema.</p><p>In children, the most common cause of acute nephritic syndrome is poststreptococcal GN [<a href="#rid16">16-18</a>]. Acute GN (GN) also has been associated with other infectious agents  (<a class="graphic graphic_table graphicRef76710" href="/z/d/graphic/76710.html" rel="external">table 2</a>). Other causes of acute nephritic syndrome include other GN (eg, IgA vasculitis [IgAV; Henoch-Schönlein purpura (HSP)], nephritis associated with subacute bacterial endocarditis, and shunt nephritis). (See  <a class="medical medical_review" href="/z/d/html/6118.html" rel="external">"Poststreptococcal glomerulonephritis"</a> and  <a class="medical medical_review" href="/z/d/html/6406.html" rel="external">"IgA vasculitis (Henoch-Schönlein purpura): Clinical manifestations and diagnosis", section on 'Kidney disease'</a> and  <a class="medical medical_review" href="/z/d/html/3054.html" rel="external">"Kidney disease in the setting of infective endocarditis or an infected ventriculoatrial shunt", section on 'Clinical features and kidney biopsy findings'</a>.)</p><p>In addition, several causes of chronic GN may present as acute nephritic syndrome and may be initially indistinguishable clinically from acute disorders. These chronic conditions include primary GN (eg, IgA nephropathy and membranoproliferative GN [MPGN]) and secondary GN (eg, lupus nephritis). (See  <a class="medical medical_review" href="/z/d/html/3112.html" rel="external">"IgA nephropathy: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/3055.html" rel="external">"Membranoproliferative glomerulonephritis: Classification, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/3056.html" rel="external">"Lupus nephritis: Diagnosis and classification"</a>.)</p><p class="headingAnchor" id="H8"><span class="h3">Rapidly progressive glomerulonephritis</span><span class="headingEndMark"> — </span>Rapidly progressive GN (RPGN) is a clinical syndrome manifested by features of subacute nephritic syndrome with a progressive loss of kidney function over a comparatively short period of time (days, weeks, or months). It is characterized morphologically by extensive crescent formation  (<a class="graphic graphic_picture graphicRef68861 graphicRef76472 graphicRef63060 graphicRef78020" href="/z/d/graphic/68861.html" rel="external">picture 1A-D</a>).</p><p>RPGN occurs rarely in children. Causes of pediatric RPGN include [<a href="#rid19">19</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Primary GN – IgA nephropathy, MPGN, and anti-glomerular basement membrane (GBM) disease</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Secondary GN – Antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis, lupus nephritis, poststreptococcal GN, IgAV (HSP) nephritis</p><p></p><p>Early diagnosis with kidney biopsy and serologic testing as well as early initiation of appropriate therapy are essential to minimize the degree of irreversible kidney injury. Empiric therapy may be started in patients with severe disease, particularly if either kidney biopsy or interpretation of the biopsy will be delayed. However, despite aggressive treatment, approximately one-half of the affected children will develop end-stage kidney disease.</p><p>The clinical manifestations, diagnosis, and treatment of RPGN are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/3113.html" rel="external">"Overview of the classification and treatment of rapidly progressive (crescentic) glomerulonephritis"</a>.)</p><p class="headingAnchor" id="H9"><span class="h3">Recurrent macroscopic hematuria</span><span class="headingEndMark"> — </span>Recurrent macroscopic hematuria in children is commonly caused by IgA nephropathy, which often occurs one or two days after an upper respiratory infection. (See  <a class="medical medical_review" href="/z/d/html/3112.html" rel="external">"IgA nephropathy: Clinical features and diagnosis", section on 'Clinical features'</a>.)</p><p>Recurrent macroscopic hematuria may also be seen in children with Alport syndrome. (See  <a class="medical medical_review" href="/z/d/html/6093.html" rel="external">"Clinical manifestations, diagnosis, and treatment of Alport syndrome (hereditary nephritis)", section on 'Kidney manifestations'</a>.)</p><p class="headingAnchor" id="H10"><span class="h3">Chronic glomerulonephritis</span><span class="headingEndMark"> — </span>Patients who present with chronic GN may have few overt symptoms, and asymptomatic hematuria or proteinuria discovered on routine urinalysis may be the only presenting sign. In addition, causes of chronic GN may present as acute nephritic syndrome and may be initially indistinguishable clinically from acute disorders.</p><p>In some cases, patients are diagnosed in a late stage of disease and present with hypertension, kidney impairment, and proteinuria with or without hematuria. The kidney biopsy at this stage may only demonstrate nonspecific and nondiagnostic findings of fibrosis, glomerular sclerosis, and tubular atrophy on light microscopy. Immunofluorescence microscopy may be more helpful in making a diagnosis.</p><p>Chronic GN that presents in childhood includes both primary GN (eg, MPGN, IgA nephropathy, and anti-GBM disease) and secondary GN (eg, lupus nephritis and ANCA-associated vasculitis).</p><p class="headingAnchor" id="H11"><span class="h2">Histopathology</span><span class="headingEndMark"> — </span>A kidney biopsy may be needed to determine the histologic etiology of GN or confirm the diagnosis. In some cases, the diagnosis can be made clinically and a biopsy is not required (eg, poststreptococcal GN). Histopathology also allows to diagnose active lesions potentially reversible with therapeutic interventions or chronic and irreversible lesions.</p><p>The histopathologic evaluation consists of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Light microscopy</p><p class="bulletIndent1"><span class="glyph">●</span>Immunofluorescence examination</p><p class="bulletIndent1"><span class="glyph">●</span>Electron microscopy</p><p></p><p class="headingAnchor" id="H12"><span class="h3">Light microscopy</span><span class="headingEndMark"> — </span>The light microscopic findings generally are not specific, as the same morphological pattern may be produced by a number of different diseases. As an example, MPGN can be caused by a variety of systemic immune complex diseases, including infective endocarditis or hepatitis C viruses, or can be a primary idiopathic disorder. (See  <a class="medical medical_review" href="/z/d/html/3055.html" rel="external">"Membranoproliferative glomerulonephritis: Classification, clinical features, and diagnosis"</a>.)</p><p>In addition, a specific disease may present with several different histologic patterns. As an example, lupus nephritis can present as six different histologic patterns on kidney biopsy. (See  <a class="medical medical_review" href="/z/d/html/3056.html" rel="external">"Lupus nephritis: Diagnosis and classification"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Minimal mesangial lupus nephritis (class I)</p><p class="bulletIndent1"><span class="glyph">●</span>Mesangial proliferative lupus nephritis (class II)</p><p class="bulletIndent1"><span class="glyph">●</span>Focal lupus nephritis (class III)</p><p class="bulletIndent1"><span class="glyph">●</span>Diffuse lupus nephritis (class IV)</p><p class="bulletIndent1"><span class="glyph">●</span>Membranous lupus nephropathy (class V)</p><p class="bulletIndent1"><span class="glyph">●</span>Advanced sclerosing lupus nephritis (class VI)</p><p></p><p>Despite the diagnostic limitation of light microscopy, it is a generally useful tool because histologic findings often correlate with the clinical status and prognosis of the patient. (See  <a class="medical medical_review" href="/z/d/html/3041.html" rel="external">"Glomerular disease: Evaluation and differential diagnosis in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Diffuse proliferative GN is associated with inflammatory lesions in most or all of the glomeruli. Patients may have significant and serious clinical findings, including nephrotic range proteinuria, edema, hypertension, and impaired kidney function.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Focal GN is associated with inflammatory lesions in less than one-half of the glomeruli. In contrast with diffuse proliferative GN, patients with focal involvement generally do not have serious clinical findings and have a better prognosis.</p><p></p><p class="headingAnchor" id="H13"><span class="h3">Immunofluorescence microscopy</span><span class="headingEndMark"> — </span>Immunofluorescence microscopy demonstrates the pattern of immunoglobulin and complement glomerular deposition, which is helpful in identifying specific kidney disorders among the different causes of GN  (<a class="graphic graphic_algorithm graphicRef74379" href="/z/d/graphic/74379.html" rel="external">algorithm 1</a>).</p><p class="bulletIndent1"><span class="glyph">●</span>Linear deposition of IgG along the GBM is diagnostic for anti-GBM GN.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Granular deposits are characteristic of immune complex diseases. The pattern of deposition is based on the immunosera used (eg, anti-IgG, anti-IgA, anti-C3) and is used to diagnose specific GN, as demonstrated by the following examples:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>IgA deposition greater than IgG deposition in the mesangium is characteristic for either IgA nephropathy or IgAV (HSP) nephritis  (<a class="graphic graphic_picture graphicRef69895" href="/z/d/graphic/69895.html" rel="external">picture 2</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>IgG and C3 deposition that is on the external side of the GBM is characteristic of poststreptococcal GN  (<a class="graphic graphic_picture graphicRef56846" href="/z/d/graphic/56846.html" rel="external">picture 3</a>), whereas IgG and C3 deposition found along the GBM and mesangium are seen in MPGN types I and III  (<a class="graphic graphic_picture graphicRef55237" href="/z/d/graphic/55237.html" rel="external">picture 4</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>IgG, mainly IgG1 and IgG3, together with IgA, IgM, C3, C4, and C1q, also called <em>full house</em>, is highly suggestive of lupus nephritis.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Deposits that only contain C3 without IgG along the glomerular, tubular, and Bowman's capsule basement membranes, and the mesangium is characteristic of dense deposit disease (MPGN type II) and C3 glomerulopathy [<a href="#rid20">20,21</a>]. (See  <a class="medical medical_review" href="/z/d/html/3090.html" rel="external">"C3 glomerulopathies: Dense deposit disease and C3 glomerulonephritis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Absence of immunoglobulins is characteristic of pauci-immune GN that is seen in patients with ANCA-associated vasculitis [<a href="#rid22">22</a>]. (See  <a class="medical medical_review" href="/z/d/html/3117.html" rel="external">"Granulomatosis with polyangiitis and microscopic polyangiitis: Clinical manifestations and diagnosis", section on 'Histopathology'</a>.)</p><p></p><p class="headingAnchor" id="H14"><span class="h3">Electron microscopy</span><span class="headingEndMark"> — </span>Electron microscopy may be useful in confirming or making a specific diagnosis of an underlying kidney disorder. As an example, electron microscopy demonstrates the characteristic subepithelial "humps" seen in patients with poststreptococcal GN  (<a class="graphic graphic_picture graphicRef76739" href="/z/d/graphic/76739.html" rel="external">picture 5</a>). (See  <a class="medical medical_review" href="/z/d/html/6118.html" rel="external">"Poststreptococcal glomerulonephritis"</a>.)</p><p class="headingAnchor" id="H15"><span class="h1">SPECIFIC DISORDERS</span><span class="headingEndMark"> — </span>Specific glomerulonephritides in children are divided into primary GN [<a href="#rid23">23</a>] (disease process isolated to the kidney) or secondary GN (kidney disease is a component of a systemic disorder), and many are discussed individually elsewhere  (<a class="graphic graphic_table graphicRef52094" href="/z/d/graphic/52094.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H16"><span class="h2">Primary glomerulonephritis</span></p><p class="bulletIndent1"><span class="glyph">●</span>Membranoproliferative GN (MPGN) (see  <a class="medical medical_review" href="/z/d/html/3055.html" rel="external">"Membranoproliferative glomerulonephritis: Classification, clinical features, and diagnosis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>IgA nephropathy (see  <a class="medical medical_review" href="/z/d/html/3112.html" rel="external">"IgA nephropathy: Clinical features and diagnosis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anti-glomerular basement membrane (GBM) disease (see  <a class="medical medical_review" href="/z/d/html/3108.html" rel="external">"Anti-GBM (Goodpasture) disease: Pathogenesis, clinical manifestations, and diagnosis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Idiopathic crescentic GN (see  <a class="medical medical_review" href="/z/d/html/3113.html" rel="external">"Overview of the classification and treatment of rapidly progressive (crescentic) glomerulonephritis"</a>)</p><p></p><p class="headingAnchor" id="H17"><span class="h2">Secondary glomerulonephritis</span></p><p class="bulletIndent1"><span class="glyph">●</span>Poststreptococcal GN (see  <a class="medical medical_review" href="/z/d/html/6118.html" rel="external">"Poststreptococcal glomerulonephritis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>IgA vasculitis (Henoch-Schönlein purpura [HSP]) (see  <a class="medical medical_review" href="/z/d/html/6406.html" rel="external">"IgA vasculitis (Henoch-Schönlein purpura): Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/3107.html" rel="external">"IgA vasculitis (Henoch-Schönlein purpura): Kidney manifestations"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Systemic lupus erythematosus nephritis (see  <a class="medical medical_review" href="/z/d/html/3056.html" rel="external">"Lupus nephritis: Diagnosis and classification"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (see  <a class="medical medical_review" href="/z/d/html/3117.html" rel="external">"Granulomatosis with polyangiitis and microscopic polyangiitis: Clinical manifestations and diagnosis"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Nephritis associated with infective endocarditis (see  <a class="medical medical_review" href="/z/d/html/5768.html" rel="external">"Infective endocarditis in children", section on 'Complications'</a>)</p><p></p><p class="headingAnchor" id="H7546412"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/z/d/html/17206.html" rel="external">"Patient education: Glomerular disease (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H18"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview</strong> – Glomerulonephritis (GN) generally presents as a constellation of findings that include hematuria, proteinuria, edema, and, often, hypertension. It is caused by a number of disorders that are all characterized by glomerular injury accompanied by inflammation. (See <a class="local">'Clinical presentation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis</strong> – The pathogenesis of GN is not fully understood. Currently available data suggest that most cases of GN are due to an immunologic response to a variety of different etiologic agents. The immunologic response, in turn, activates a number of biologic processes (eg, complement activation, leukocyte recruitment, and release of growth factors and cytokines), which result in glomerular inflammation and injury. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Classification</strong> – Because the differential diagnosis for GN is broad, using a classification schema is helpful to narrow the causes of GN in a systematic manner. The etiology of GN in children can be classified by its clinical presentation (acute GN, rapidly progressive GN [RPGN], recurrent macroscopic hematuria, and chronic GN) or by histopathology. The histologic findings are based on light, immunofluorescence, and electron microscopy. (See <a class="local">'Etiologic classification'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Specific disorders</strong> – GN may be isolated to the kidney (primary GN) or be a component of a systemic disorder (secondary GN)  (<a class="graphic graphic_table graphicRef52094" href="/z/d/graphic/52094.html" rel="external">table 1</a>). Specific causes of GN in children are discussed in separate reviews. (See <a class="local">'Specific disorders'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Sethi S, De Vriese AS, Fervenza FC. Acute glomerulonephritis. Lancet 2022; 399:1646.</a></li><li><a class="nounderline abstract_t">Couser WG. Pathogenesis and treatment of glomerulonephritis-an update. J Bras Nefrol 2016; 38:107.</a></li><li><a class="nounderline abstract_t">Couser WG, Johnson RJ. The etiology of glomerulonephritis: roles of infection and autoimmunity. Kidney Int 2014; 86:905.</a></li><li><a class="nounderline abstract_t">Chadban SJ, Atkins RC. Glomerulonephritis. Lancet 2005; 365:1797.</a></li><li><a class="nounderline abstract_t">Couser WG. Pathogenesis of glomerulonephritis. Kidney Int Suppl 1993; 42:S19.</a></li><li><a class="nounderline abstract_t">Hellmark T, Burkhardt H, Wieslander J. Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies. J Biol Chem 1999; 274:25862.</a></li><li><a class="nounderline abstract_t">Anders HJ, Kitching AR, Leung N, Romagnani P. Glomerulonephritis: immunopathogenesis and immunotherapy. Nat Rev Immunol 2023; 23:453.</a></li><li><a class="nounderline abstract_t">Brouwer E, Stegeman CA, Huitema MG, et al. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG). Clin Exp Immunol 1994; 98:448.</a></li><li><a class="nounderline abstract_t">Cairns LS, Phelps RG, Bowie L, et al. The fine specificity and cytokine profile of T-helper cells responsive to the alpha3 chain of type IV collagen in Goodpasture's disease. J Am Soc Nephrol 2003; 14:2801.</a></li><li><a class="nounderline abstract_t">Wu J, Hicks J, Borillo J, et al. CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis. J Clin Invest 2002; 109:517.</a></li><li><a class="nounderline abstract_t">Summers SA, Steinmetz OM, Li M, et al. Th1 and Th17 cells induce proliferative glomerulonephritis. J Am Soc Nephrol 2009; 20:2518.</a></li><li><a class="nounderline abstract_t">Nangaku M. Complement regulatory proteins in glomerular diseases. Kidney Int 1998; 54:1419.</a></li><li><a class="nounderline abstract_t">Kilgore KS, Schmid E, Shanley TP, et al. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. Am J Pathol 1997; 150:2019.</a></li><li><a class="nounderline abstract_t">Hughes J, Nangaku M, Alpers CE, et al. C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis. Am J Physiol Renal Physiol 2000; 278:F747.</a></li><li><a class="nounderline abstract_t">Atkins RC, Nikolic-Paterson DJ, Song Q, Lan HY. Modulators of crescentic glomerulonephritis. J Am Soc Nephrol 1996; 7:2271.</a></li><li><a class="nounderline abstract_t">Rodriguez-Iturbe B. Postinfectious glomerulonephritis. Am J Kidney Dis 2000; 35:XLVI.</a></li><li><a class="nounderline abstract_t">Zhang Y, Shen Y, Feld LG, Stapleton FB. Changing pattern of glomerular disease at Beijing Children's Hospital. Clin Pediatr (Phila) 1994; 33:542.</a></li><li><a class="nounderline abstract_t">Sanjad S, Tolaymat A, Whitworth J, Levin S. Acute glomerulonephritis in children: a review of 153 cases. South Med J 1977; 70:1202.</a></li><li><a class="nounderline abstract_t">Mayer U, Schmitz J, Bräsen JH, Pape L. Crescentic glomerulonephritis in children. Pediatr Nephrol 2020; 35:829.</a></li><li><a class="nounderline abstract_t">Riedl M, Thorner P, Licht C. C3 Glomerulopathy. Pediatr Nephrol 2017; 32:43.</a></li><li><a class="nounderline abstract_t">Vivarelli M, van de Kar N, Labbadia R, et al. A clinical approach to children with C3 glomerulopathy. Pediatr Nephrol 2022; 37:521.</a></li><li><a class="nounderline abstract_t">Plumb LA, Oni L, Marks SD, Tullus K. Paediatric anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: an update on renal management. Pediatr Nephrol 2018; 33:25.</a></li><li><a class="nounderline abstract_t">Floege J, Amann K. Primary glomerulonephritides. Lancet 2016; 387:2036.</a></li></ol></div><div id="topicVersionRevision">Topic 6117 Version 29.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35461559" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Acute glomerulonephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27049372" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Pathogenesis and treatment of glomerulonephritis-an update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24621918" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The etiology of glomerulonephritis: roles of infection and autoimmunity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15910953" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Glomerulonephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8361123" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Pathogenesis of glomerulonephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10464328" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Goodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36635359" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Glomerulonephritis: immunopathogenesis and immunotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7994909" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14569090" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The fine specificity and cytokine profile of T-helper cells responsive to the alpha3 chain of type IV collagen in Goodpasture's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11854324" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : CD4(+) T cells specific to a glomerular basement membrane antigen mediate glomerulonephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19820122" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Th1 and Th17 cells induce proliferative glomerulonephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9844117" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Complement regulatory proteins in glomerular diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9176395" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10807586" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8959617" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Modulators of crescentic glomerulonephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10620563" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Postinfectious glomerulonephritis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8001323" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Changing pattern of glomerular disease at Beijing Children's Hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/333598" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Acute glomerulonephritis in children: a review of 153 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32052153" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Crescentic glomerulonephritis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27056062" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : C3 Glomerulopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34002292" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : A clinical approach to children with C3 glomerulopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28062909" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Paediatric anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: an update on renal management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26921911" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Primary glomerulonephritides.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
